We validated the in vivo effects of HRD1 on the growth of breast cancer cells by injecting MB231 cells stable overexpressing HRD1 or the corresponding controls into the right flank and left flank of nude mice, respectively. This evidence concerns the gene SYVN1 and breast cancer.